<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Obstetrics and Gynecology</journal-id><journal-title-group><journal-title xml:lang="en">Obstetrics and Gynecology</journal-title><trans-title-group xml:lang="ru"><trans-title>Акушерство и гинекология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0300-9092</issn><issn publication-format="electronic">2412-5679</issn><publisher><publisher-name xml:lang="en">Bionika Media</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">247905</article-id><article-id pub-id-type="doi">10.18565/aig.2017.3.50-4</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The levels of interleukin-6, soluble interleukin-6 and vascular endothelial growth factor receptors during delivery at term, threatened preterm labor, and in preeclampsia</article-title><trans-title-group xml:lang="ru"><trans-title>Уровень интерлейкина-6, растворимых рецепторов интерлейкина-6, сосудисто-эндотелиального фактора роста при срочных родах, угрозе преждевременных родов и преэклампсии</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shcherbakov</surname><given-names>Vladimir Ivanovich</given-names></name><name xml:lang="ru"><surname>Щербаков</surname><given-names>Владимир Иванович</given-names></name></name-alternatives><bio xml:lang="en"><p>doctor of medical sciences, research fellow of the Immunology Laboratory</p></bio><bio xml:lang="ru"><p>д.м.н., научный сотрудник лаборатории иммунологии</p></bio><email>Shcherbakov_VI@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pozdnyakov</surname><given-names>Ivan Mikhailovich</given-names></name><name xml:lang="ru"><surname>Поздняков</surname><given-names>Иван Михайлович</given-names></name></name-alternatives><bio xml:lang="en"><p>Doctor of Medical Sciences, Professor of the Department of Obstetrics and Gynecology; Chief Physician</p></bio><bio xml:lang="ru"><p>д.м.н., профессор кафедры акушерства и гинекологии; главный врач</p></bio><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shirinskaya</surname><given-names>Anna Vladimirovna</given-names></name><name xml:lang="ru"><surname>Ширинская</surname><given-names>Анна Владимировна</given-names></name></name-alternatives><bio xml:lang="en"><p>obstetrician-gynecologist women’s consultation No. 2.</p></bio><bio xml:lang="ru"><p>врач акушер-гинеколог, женская консультация № 2</p></bio><email>anncharm2004@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Volkov</surname><given-names>Mikhail Valentinovich</given-names></name><name xml:lang="ru"><surname>Волков</surname><given-names>Михаил Валентинович</given-names></name></name-alternatives><bio xml:lang="en"><p>obstetrician-gynecologist, women’s consultation</p></bio><bio xml:lang="ru"><p>врач акушер-гинеколог, женская консультация</p></bio><email>michaelis67@mail.ru</email><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research Institute of Experimental and Clinical Medicine</institution></aff><aff><institution xml:lang="ru">ФГБНУ Научно-исследовательский институт экспериментальной и клинической медицины</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Novosibirsk State Medical University</institution></aff><aff><institution xml:lang="ru">ГБОУ ВПО НГМУ Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Novosibirsk City Clinical Perinatal Center</institution></aff><aff><institution xml:lang="ru">ГБУЗ НСО Новосибирский городской клинический перинатальный центр</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Clinical Maternity Hospital Six</institution></aff><aff><institution xml:lang="ru">ГБУЗ НО Клинический родильный дом № 6</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-03-15" publication-format="electronic"><day>15</day><month>03</month><year>2017</year></pub-date><issue>3</issue><issue-title xml:lang="en">NO3 (2017)</issue-title><issue-title xml:lang="ru">№3 (2017)</issue-title><fpage>50</fpage><lpage>54</lpage><history><date date-type="received" iso-8601-date="2023-02-18"><day>18</day><month>02</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Bionika Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, ООО «Бионика Медиа»</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Bionika Media</copyright-holder><copyright-holder xml:lang="ru">ООО «Бионика Медиа»</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0300-9092/article/view/247905">https://journals.eco-vector.com/0300-9092/article/view/247905</self-uri><abstract xml:lang="en"><p>Objective. To study of the serum levels of Interleukin-6 (IL-6), soluble IL-6 and vascular endothelial growth factor (VEGF) receptors in women during delivery at term, threatened preterm labor, and in preeclampsia. Subjects and methods. A total of 85 pregnant women who were divided into 4 groups were examined. Group 1 included 35 women with physiological delivery; Group 2 consisted of 11 with threatened preterm labor; Group 3 comprised 23 with preeclampsia; Group 4 (a control group) included 16 with physiological pregnancy. A solidphase enzyme-linked immunoabsorbent assay was used to determine the serum levels of IL-6, soluble IL-6 and VEGF receptors. Results. The level of IL-6 was shown to increase dramatically in women with physiological delivery while the level in those with threatened preterm labor was approximately the same as that in the controls. The content of soluble IL-6 receptor was opposite to that of IL-6. The level of soluble VEGF receptor 1 reduced in threatened preterm labor and increases in physiological delivery and preeclampsia.</p></abstract><trans-abstract xml:lang="ru"><p>Цель исследования. Изучение содержания в сыворотке крови интерлейкина-6 (ИЛ-6), растворимых рецепторов ИЛ-6 и сосудисто-эндотелиального фактора роста (СЭФР) при срочных родах, угрозе преждевременных родов и преэклампсии. Материал и методы. Обследованы 85 беременных, которые были разделены на 4 группы. Первая группа (35 человек) - с физиологическими родами, вторая группа (11 человек) - с угрозой преждевременных родов, третья группа (23 человека) - с преэклампсией, четвертая группа (16 человек) - контроль с физиологическим течением беременности. В сыворотке крови методом твердофазного иммуноферментного анализа определялись ИЛ-6, растворимые рецепторы ИЛ-6 и СЭФР. Результаты исследования. Показано, что при физиологических родах уровень ИЛ-6 резко повышается, в то время как при угрозе преждевременных родов уровень ИЛ-6 был примерно такой же, как в контроле. Уровень растворимого рецептора ИЛ-6 был противоположным по сравнению с ИЛ-6. Уровень растворимого рецептора 1 СЭФР снижается при угрозе преждевременных родов, повышается при физиологических родах и преэклампсии.</p></trans-abstract><kwd-group xml:lang="en"><kwd>preeclampsia</kwd><kwd>preterm labor</kwd><kwd>interleukin-6</kwd><kwd>soluble receptors</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>преэклампсия</kwd><kwd>преждевременные роды</kwd><kwd>интерлейкин-6</kwd><kwd>растворимые рецепторы</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Скрипченко Ю.П., Баранов И.И., Токова З.З. Статистика преждевременных родов. Проблемы репродукции. 2014; 20(4): 11-4. [Skripchenko Yu.P., Baranov II, Tokova Z.Z. Statistics of premature birth. Problemy reproduktsii. 2014; 20 (4): 11-4. (in Russian)]</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Wakabayashi A., Sawada K., Nakayama M., Toda A., Kimoto A., Mabuchi S. et al. Targeting interleukin-6 receptor inhibits preterm delivery induced by inflammation. Mol. Hum. Reprod. 2013; 9(11): 718-26.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Щербаков В.И., Рябиченко Т.И., Скосырева Г.А., Трунов А.Н. Механизмы внутриутробного программирования ожирения у детей. Российский вестник перинатологии и педиатрии. 2013; 58(5): 8-14. [Shcherbakov V.I., Ryabichenko T.I., Skosyreva G.A., Trunov A.N. Mechanisms of intrauterine programming of obesity in children. The Rossiyskiy vestnik perinatologii i pediatrii. 2013; 58 (5): 8-14. (in Russian)]</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Fowden A.L., Giussani D.A., Forhead A.J. Intrauterine programming of physiological systems: causes and consequences. Physiology (Bethesda). 2006; 21: 29-37.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Макаров О.В., Волкова Е.В., Лысюк Е.Ю., Копылова Ю.В., Джохадзе Л.С. Роль ангиогенных факторов роста в патогенезе преэклампсии и плацентарной недостаточности. Акушерство и гинекология. 2014; 12: 64-70. [Makarov O.V., Volkova E.V., Lysyuk E.Yu., Kopylova Yu.V., Dzhokhadze L.S. Role of angiogenic growth factors in the pathogenesis of preeclampsia and placental insufficiency. Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2014; (12): 64-70. (in Russian)]</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Gomez-Lopez N., Laresgoiti-Servitje E., Olson D.M., Estrada- Gutiérrez G., Vadillo-Ortega F. The role of chemokine in term and pre mature rupture of the fetal membranes: a review. Biol. Reprod. 2010; 82(5): 809-14.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Srikhajon K., Shynlova O., Preechapornprasert A., Chanrachakul B., Lye S. A new role for monocytes in modulating myometrial inflammation during human labor. Biol. Reprod. 2014; 91(1): 10-21.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Thomson A.J., Telfer J.F, Young A., Campbell S., Stewart C.J., Cameron I.T. et al. Leukocytes infiltrate the myometrium during human parturition: further evidence that labour is s an inflammatory process. Hum. Reprod. 1999; 14(1): 229-36.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Щербаков В.И. Плацента и ее роль в патогенезе преэклампсии. Новосибирск: СГУПС; 2012. 200с. [Shcherbakov V.I. Placenta and its role in the pathogenesis of preeclampsia. Novosibirsk: SGUPS; 2012. 200p. (in Russian)</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Croll S.D., Ransohoff R.M., Cai N., Zhang Q., Martin F.J., Wei T. et al. VEGF-mediated inflammation precedes angiogenesis in adult brain. Exp. Neurol. 2004; 187(2): 388-402.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Pennington K.A., Schlitt J.M., Jackson D.L., Schulz L.C., Schust D.J. Preeclampsia: multiple approaches for a multifactorial disease. Dis. Model. Mech. 2012; 5(1): 9-18.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Petersen A.M.W., Pedersen B.K. The anti-inflammatory effect of exercise. J. Appl. Physiol. 2005; 98(4): 1154-62.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Pedersen B.K., Febbrao M.A. Muscule as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 2008; 88(4): 1379-406.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Rajagopal S.P., Hutchinson J.L., Dorward D.A., Rossi A.G., Norman J.E. Crosstalk between monocytes and myometrial smooth muscle in culture generates synergistic pro-inflammatory cytokine production and enhances myocyte contraction, with effects opposed progesterone. Mol. Hum. Reprod. 2015; 21(8): 672-86.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Febbraio M.A., Pedersen B.K. Muscle derived interleikin-6: mechanisms for activation and possible biological roles. FASEB J. 2002; 16(11): 1335-47.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Prins J.R., Gomez-Lopez N., Robertson S.A. Interleukin-6 in pregnancy and gestational disorders. J. Reprod. Immunol. 2012; 25(1-2): 1-14.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>McLoughlin R.M., Hurst S.M., Nowell M.A., Harris D.A., Horiuchi S., Morgan L.W. et al. Differential regulation of neutrophils-activating chemokines by IL-6 and ist soluble receptor isoforms. J. Immunol. 2004; 172(9): 5676-83.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Rana S., Karumanchi S.A., Levine R.J., Venkatesha S., Rauh-Hain J.A., Tamez H., Thadhani R. Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension. 2007; 50(1): 137-42.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Cindrova-Davies T., Yung H.W., Johns J., Spasic-Boskovic O., Korolchuk S., Jauniaux E. et al. Oxidative stress, gene expression, and protein changes induced in the human placenta during labor. Am. J. Pathol. 2007; 171(4): 1168-79.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Tal R., Segars J.H. The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy. Hum. Reprod. 2014; 20(2): 194-216.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Stranghen J.K., Kumar P., Mistra V.K. The effect of maternal soluble FMS-like tyrosine kinase 1 during pregnancy on risk of preterm delivery. J. Matern. Fetal Neonatal Med. 2012; 25(10): 1679-83.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Barleon B., Sozzani S., Zhou D., Weich H.A., Mantovani A., MarméD. Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. B^d. 1996; 97(8): 3336-43.</mixed-citation></ref></ref-list></back></article>
